Doesn't your argument assume those shares are issued for no value to the company? Why does capitalization equal share price times shares outstanding? The answer is that shares held in the company's treasury are an asset of the company and when issued the company receives value. Secondary offerings can be dilutive if the company accepts less value than the PPS at the time of issue, which some companies do to stay afloat. This will not be the case with PPHM. One or more Big Pharma are well aware of SK and PPHM's pipeline. I will not be suprised if PPHM's shareholders receive a handsome partnership, merger or acquisition offer before the end of the year. I wished for a 1 for 10 reverse split but you know what happens when you hold out one hand to fill with wishes and deficate in the other.